Longevity healthcare startup Vytalyou secures ₹8–10 crore in growth capital

Summary:
Vytalyou, a Mumbai-based preventive healthcare and longevity platform, has raised Rs 8–10 crore in growth funding at an estimated valuation of Rs 33 crore. The company plans to expand its Mumbai network from its existing Powai centre to three locations with new centres in Juhu and Worli, before entering other major Indian cities in 2027. Founded in 2025, Vytalyou combines diagnostics and preventive healthcare through its Predictive Longevity Evaluation, which includes blood tests, ultrasound, body-composition and cardiovascular assessments, along with therapies such as hyperbaric oxygen treatment, cryotherapy, photobiomodulation and regenerative treatments. 

Vytalyou, a Mumbai-based preventive healthcare and longevity platform, has secured Rs 8-10 crore in growth funding at an estimated valuation of Rs 33 crore. The company plans to strengthen its presence in Mumbai and expand into other major Indian cities in 2027.

The funding was raised in August 2026 from Chetan Jain of Pharma Dose and Ratan Jain of Venus Industries. The capital will support Vytalyou’s upcoming expansion plans. The company currently runs a centre in Powai and is developing new centres in Juhu and Worli, which will take its Mumbai presence to three locations.

Vytalyou was founded by molecular oncologist Dr Chirantan Bose and radiologist Dr Preetesh Bhandari and was incorporated in September 2025. Its healthcare model combines diagnostic services with preventive care, aiming to identify potential health risks at an early stage and help improve an individual’s “healthspan”.

The company’s Predictive Longevity Evaluation includes blood tests, ultrasound scans, body-composition assessment and cardiovascular evaluation. Vytalyou also provides therapies such as hyperbaric oxygen treatment, cryotherapy, photobiomodulation and regenerative therapies.